Capsaicinoids supplementation decreases percent body fat and fat mass: adjustment using covariates in a post hoc analysis

Table 2 Percent change in percent body fat compared between active and placebo groups using model generated means (LS Means)

Contrast	Treatment	N	LS Mean (SE)	LS Mean Difference (SE)	P Value
Without Baseline Covariates
Capsimax 2 mg vs Placebo	Capsimax 2 mg	27	2.68 (1.78)	0.20	0.9939
Capsimax 2 mg vs Placebo	Placebo	28	2.70 (1.75)	0.20	0.9939
Capsimax 4 mg vs Placebo	Capsimax 4 mg	22	− 0.70 (1.97)	3.39	0.2014
Capsimax 4 mg vs Placebo	Placebo	28	2.70 (1.75)	3.39	0.2014
With Baseline Covariates
Capsimax 2 mg vs Placebo	Capsimax 2 mg	26	3.51 (2.09)	−1.47	0.6030
Capsimax 2 mg vs Placebo	Placebo	27	4.99 (2.28)	−1.47	0.6030
Capsimax 4 mg vs Placebo	Capsimax 4 mg	22	− 0.92 (2.06)	− 5.91	0.0402
Capsimax 4 mg vs Placebo	Placebo	27	4.99 (2.28)	− 5.91	0.0402

Analysis “Without Baseline Covariates” was a One-way ANOVA model. Analysis “With Baseline Covariates” was a generalized linear model containing treatment, variates and treatment x covariate interactions. Two subjects were lost to the “With Baseline Covariates” analysis due to missing values at baseline

ISSN: 2052-9538